You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR SULFAMYLON


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SULFAMYLON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00634166 ↗ Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group Terminated Mylan Pharmaceuticals Phase 4 2007-09-01 The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
NCT00634166 ↗ Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group Terminated Mylan Bertek Pharmaceuticals Phase 4 2007-09-01 The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
NCT00675922 ↗ Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks Terminated The University of Texas Medical Branch, Galveston Phase 2/Phase 3 1995-07-01 Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SULFAMYLON

Condition Name

Condition Name for SULFAMYLON
Intervention Trials
Burn 1
Burns 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SULFAMYLON
Intervention Trials
Burns 2
Wounds and Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SULFAMYLON

Trials by Country

Trials by Country for SULFAMYLON
Location Trials
United States 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SULFAMYLON
Location Trials
North Carolina 1
Missouri 1
Maryland 1
Kansas 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SULFAMYLON

Clinical Trial Phase

Clinical Trial Phase for SULFAMYLON
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SULFAMYLON
Clinical Trial Phase Trials
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SULFAMYLON

Sponsor Name

Sponsor Name for SULFAMYLON
Sponsor Trials
Mylan Pharmaceuticals 1
Mylan Bertek Pharmaceuticals 1
The University of Texas Medical Branch, Galveston 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SULFAMYLON
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.